2013
DOI: 10.1038/srep02970
|View full text |Cite
|
Sign up to set email alerts
|

No association between Epstein-Barr Virus and Mouse Mammary Tumor Virus with Breast Cancer in Mexican Women

Abstract: Breast cancer is the most frequent malignancy affecting women worldwide. It has been suggested that infection by Epstein Barr Virus (EBV), Mouse Mammary Tumor Virus or a similar virus, MMTV-like virus (MMTV-LV), play a role in the etiology of the disease. However, studies looking at the presence of these viruses in breast cancer have produced conflicting results, and this possible association remains controversial. Here, we used polymerase chain reaction assay to screen specific sequences of EBV and MMTV-LV in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
30
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 37 publications
(32 citation statements)
references
References 31 publications
1
30
1
Order By: Relevance
“…Therefore, although in silico preliminary analyses can help to predict the scope of experimental strategies, we recommend considering this difference in future studies. Notably, we found no reads for MMTV and HPV and we confirmed the absence of MMTV in BrC by PCR ( Morales-Sánchez et al 2013 ). In this study, we developed and in silico pipeline of analysis of viral sequences in tumour samples, which was then used to sequence BrC and GC tumours samples, finding evidence of EBV in GC, a result that validated the sequencing and analysis strategy.…”
Section: Discussionsupporting
confidence: 67%
“…Therefore, although in silico preliminary analyses can help to predict the scope of experimental strategies, we recommend considering this difference in future studies. Notably, we found no reads for MMTV and HPV and we confirmed the absence of MMTV in BrC by PCR ( Morales-Sánchez et al 2013 ). In this study, we developed and in silico pipeline of analysis of viral sequences in tumour samples, which was then used to sequence BrC and GC tumours samples, finding evidence of EBV in GC, a result that validated the sequencing and analysis strategy.…”
Section: Discussionsupporting
confidence: 67%
“…We determined that using 15.5 × 10 3 cells from samples (and 15.5 × 10 3 plasmid copies mixed with DNA from 15.5 × 10 3 negative cells as control) would be sufficient to detect up to one viral genome per cell even in samples with only 25% of leukemic blasts (Figures 1(b) , 1(c) , and 1(d) ). We have previously used these PCRs in which the frequency of infected cells matches the frequency of cancer cells to address direct viral oncogenesis [ 28 30 ].…”
Section: Resultsmentioning
confidence: 99%
“…2016; 11(3):e34806. (11,18,(36)(37)(38)(39)(40)(41)(42)(43)(44)(45)(46)(47)(48)(49)(50)(51)(52)(53). Table 1 shows a summary of the EBV-DNA positive subjects according to nationality, types of sample, and kinds of control tissue in the 20 selected studies.…”
Section: Resultsmentioning
confidence: 99%